ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

VP Bush Visits NIH To Learn About AIDS

April 17, 1987

NCI Separates Carcinogenesis Research Efforts

February 18, 1977

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013